Skip to main content
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1951 Jul 1;94(1):45–64. doi: 10.1084/jem.94.1.45

PASSAGE OF COXSACKIE VIRUS (CONNECTICUT-5 STRAIN) IN ADULT MICE WITH PRODUCTION OF PANCREATIC DISEASE

Alwin M Pappenheimer 1, Lawrence J Kunz 1, Sheila Richardson 1
PMCID: PMC2136094  PMID: 14850635

Abstract

1. With Conn.-5 strain of Coxsackie virus, pancreatic disease can be regularly produced in adult mice. 2. The lesions consist of widespread necrosis, followed by repair; there occurs more or less complete loss of glandular acini, with fatty or fibrous replacement. The islands of Langerhans and pancreatic ducts persist. 3. Injection of virus suspensions by the intraperitoneal, subcutaneous, intramuscular, or intracerebral route is followed by selective necrosis of the pancreas. 4. The liver, in the earlier stages of the disease, is the seat of fat infiltration. There may be necrosis of individual hepatic cells, but the diffuse hepatitis described in suckling mice does not occur. In the later stages of the disease, the liver is not significantly altered. 5. Localized areas of fat necrosis, scattered through intra-abdominal adipose tissue, are usually present in the acute phase of the disease. These undergo fibrosis without calcification. 6. No lesions have been found in the skeletal muscle, even at the site of intramuscular injection. Central nervous system, heart, lungs, and peripheral fat lobules show no lesions comparable to those described in suckling mice. 7. Multiplication of virus takes place in the pancreas. Serial passage in adult mice, by injection of pancreas suspensions prepared from organs removed on the 4th day after infection, is readily accomplished. Five consecutive passages in adult mice have thus far been carried out. Pancreas suspension from 4th passage material produced typical disease in suckling mice when diluted 10–6. No virus could be demonstrated in pancreas obtained 25 days after inoculation. 8. Complete protection against the pancreatic disease is obtained when the virus is neutralized, before injection, with Conn.-5 antiserum. Normal mouse serum and antiserum against the Ohio-R strain of Coxsackie virus have no protective effect. 9. Mice surviving the initial necrotizing effect of the virus, develop chronic pancreatic insufficiency. This is manifested by extreme weight loss—in some cases, 40 per cent or more of the body weight—and by hypoproteinemia, sometimes leading to anasarca. 10. The substitution of fox-chow which has been predigested with hog pancreas brings about a restoration of weight. 11. The possibility is considered that similar lesions of the pancreas in human beings may be due to virus infection.

Full Text

The Full Text of this article is available as a PDF (1.9 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. CHEEVER F. S., DANIELS J. B., HERSEY E. F. A viral agent isolated from a case of "non-paralytic poliomyelitis" and pathogenic for suckling mice: its possible relation to the coxsackie group of viruses. J Exp Med. 1950 Aug;92(2):153–167. doi: 10.1084/jem.92.2.153. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. CURNEN E. C. Human disease associated with the Coxsackie viruses. Bull N Y Acad Med. 1950 May;26(5):335–342. [PMC free article] [PubMed] [Google Scholar]
  3. DALLDORF G. The Coxsackie group of viruses. Science. 1949 Dec 2;110(2866):594–594. doi: 10.1126/science.110.2866.594. [DOI] [PubMed] [Google Scholar]
  4. DALLDORF G. The Coxsackie viruses. Bull N Y Acad Med. 1950 May;26(5):329–335. [PMC free article] [PubMed] [Google Scholar]
  5. MELNICK J. L., GODMAN G. C. Pathogenesis of coxsackie virus infection; multiplication of virus and evolution of the muscle lesion in mice. J Exp Med. 1951 Mar;93(3):247–266. doi: 10.1084/jem.93.3.247. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. MELNICK J. L., LEDINKO N. Immunological reactions of the Coxsackie viruses. I. The neutralization test; technic and application. J Exp Med. 1950 Nov 1;92(5):463–482. doi: 10.1084/jem.92.5.463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. MELNICK J. L., SHAW E. W., CURNEN E. C. A virus isolated from patients diagnosed as non-paralytic poliomyelitis or aseptic meningitis. Proc Soc Exp Biol Med. 1949 Jul;71(3):344–349. doi: 10.3181/00379727-71-17186. [DOI] [PubMed] [Google Scholar]
  8. MELNICK J. L. Studies on the Coxsackie viruses; properties, immunological aspects and distribution in nature. Bull N Y Acad Med. 1950 May;26(5):342–356. [PMC free article] [PubMed] [Google Scholar]
  9. PAPPENHEIMER A. M., DANIELS J. B., CHEEVER F. S., WELLER T. H. Lesions caused in suckling mice by certain viruses isolated from cases of so called non-paralytic poliomyelitis and of pleurodynia. J Exp Med. 1950 Aug;92(2):169–190. doi: 10.1084/jem.92.2.169. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Pappenheimer A. M. Muscular dystrophy in mice on vitamin E-deficient diet. Am J Pathol. 1942 Mar;18(2):169–181. [PMC free article] [PubMed] [Google Scholar]
  11. Pappenheimer A. M., Victor J. "Ceroid" Pigment in Human Tissues. Am J Pathol. 1946 Mar;22(2):395–413. [PMC free article] [PubMed] [Google Scholar]
  12. Victor J., Pappenheimer A. M. THE INFLUENCE OF CHOLINE, CYSTINE, AND OF alpha-TOCOPHEROL UPON THE OCCURRENCE OF CEROID PIGMENT IN DIETARY CIRRHOSIS OF RATS. J Exp Med. 1945 Nov 30;82(6):375–383. [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES